You are here: Prostate Cancer > Information > Background > Prostate Cancer > Recurrent prostate cancer
|Higher radiation dose reduces recurrence of local prostate cancer|
After nearly nine years of follow-up, men with early-stage prostate cancer who received higher doses of radiation were less likely than men who received the conventional dose to have rising levels of prostate-specific antigen (PSA)"”a phenomenon referred to as "biochemical recurrence" that may predict actual recurrence 15 years or more in the future.
This is a news item reporting the findings of a phase III trial that men with early-stage prostate cancer who receive higher doses of radiation were half as likely to see their cancer return in five years as men who received the conventional dose.
We assessed this page using an appraisal instrument developed by Minervation specifically for this project. This approach is still in development, so you should regard the assessments as a general guide. Click here to find out more, or to let us know how you think the approach could be improved.
National Cancer Institute (NCI)